Results 351 to 360 of about 1,140,283 (405)

Concomitant Use of Oral Anticoagulants With Oral Dipeptidyl Peptidase‐4 Inhibitors and Serious Bleeding Events

open access: yesClinical Pharmacology &Therapeutics, Volume 117, Issue 4, Page 1012-1016, April 2025.
In a prior screening study, saxagliptin, a dipeptidyl peptidase‐4 inhibitor (DPP‐4i), was found to have an increased rate of serious bleeding when used concomitantly with several oral anticoagulants (OACs). We aimed to confirm or refute the associations between concomitant use of individual OACs and DPP‐4is and serious bleeding in a large US database ...
Thanh Phuong Pham Nguyen   +8 more
wiley   +1 more source

Correction: Examining the Emotional and Physical Health Impact in Users of Open-Source Automated Insulin Delivery and Sources of Support: Qualitative Analysis of Patient Narratives.

open access: yesJ Med Internet Res
Cleal B   +14 more
europepmc   +1 more source

Discovering Severe Adverse Reactions From Pharmacokinetic Drug–Drug Interactions Through Literature Analysis and Electronic Health Record Verification

open access: yesClinical Pharmacology &Therapeutics, Volume 117, Issue 4, Page 1078-1087, April 2025.
While drug–drug interactions (DDIs) and their pharmacokinetic (PK) mechanisms are well‐studied prior to drug approval, severe adverse drug reactions (SADRs) caused by DDIs often remain underrecognized due to limitations in pre‐marketing clinical trials.
Eugene Jeong, Yu Su, Lang Li, You Chen
wiley   +1 more source

The journey to building a diverse, equitable, and inclusive American Medical Informatics Association. [PDF]

open access: yesJ Am Med Inform Assoc
Bright TJ   +11 more
europepmc   +1 more source

MedBot vs RealDoc: efficacy of large language modeling in physician-patient communication for rare diseases. [PDF]

open access: yesJ Am Med Inform Assoc
Weber MT   +9 more
europepmc   +1 more source

Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy.

open access: yesJAMA Ophthalmol
Cai CX   +57 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy